affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →
AOD-9604 vs Cagrilintide
Two compounds, mechanism by mechanism. Where they overlap, where they don't, and which vendors stock each.
Mechanism
AOD-9604
Synthetic 16-amino-acid fragment of human growth hormone (residues 176–191). Selectively retains the lipolytic effect of HGH while reducing growth-related effects.
Full guide →Cagrilintide
Synthetic long-acting amylin analog. Activates amylin and calcitonin receptors. Studied in combination with semaglutide as CagriSema in Phase 3 obesity trials.
Full guide →Key facts
Use-case overlap
- fat metabolism research
- lipolysis studies
- HGH fragment research
none
- weight management research
- amylin-analog studies
- GLP-1 combination protocols
Where to buy
Sources
- [01]AOD-9604 and obesity research — Obesity Reviews· AOD-9604
- [02]AOD-9604 Phase 2 trial results· AOD-9604
- [03]Cagrilintide and semaglutide combination — The Lancet· Cagrilintide
- [04]Novo Nordisk CagriSema Phase 3 program· Cagrilintide
Other peptide matchups
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.